Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays

Autor: Matthew Drew, Vanessa Wall, Kaitlyn Sadtler, Troy Taylor, Dominic Esposito, William K. Gillette, John-Paul Denson, Kelly Snead, Simon Messing, Jennifer Mehalko
Jazyk: angličtina
Rok vydání: 2021
Předmět:
0106 biological sciences
Signal peptide
TFF
tangential flow filtration

Population
Enzyme-Linked Immunosorbent Assay
Antibodies
Viral

AnSEC
analytical size exclusion chromatography

01 natural sciences
Article
Serology
03 medical and health sciences
chemistry.chemical_compound
RBD
receptor binding domain

Antigen
Protein Domains
010608 biotechnology
Protein biosynthesis
Protein production
Humans
IMAC
immobilized metal ion affinity chromatography

education
CV
column volume

030304 developmental biology
0303 health sciences
education.field_of_study
Chemistry
SARS-CoV-2
SDS-PAGE
sodium dodecyl sulfate-polyacrylamide gel electrophoresis

COVID-19
Promoter
ELISA
enzyme-linked immunosorbent assay

MWCO
molecular weight cut-off

SBP
streptavidin-binding peptide

Receptor-binding domain
Biochemistry
Cell culture
Spike Glycoprotein
Coronavirus

ELISA
SEC
size exclusion chromatography

DNA
Protein Binding
Biotechnology
Zdroj: Protein Expression and Purification
bioRxiv
article-version (status) pre
article-version (number) 1
ISSN: 1046-5928
DOI: 10.1016/j.pep.2020.105802
Popis: The receptor-binding domain (RBD) of the SARS-CoV-2 spike protein is a commonly used antigen for serology assays critical to determining the extent of SARS-CoV-2 exposure in the population. Different versions of the RBD protein have been developed and utilized in assays, with higher sensitivity attributed to particular forms of the protein. To improve the yield of these high-sensitivity forms of RBD and support the increased demand for this antigen in serology assays, we investigated several protein expression variables including DNA elements such as promoters and signal peptides, cell culture expression parameters, and purification processes. Through this investigation, we developed a simplified and robust purification strategy that consistently resulted in high levels of the high-sensitivity form of RBD and demonstrated that a carboxyterminal tag is responsible for the increased sensitivity in the ELISA. These improved reagents and processes produce high-quality proteins which are functional in serology assays and can be used to investigate seropositivity to SARS-CoV-2 infection.
Highlights • Improved yields of SARS-CoV-2 spike RBD through modification of DNA constructs and purification parameters. • Two versions of RBD show different sensitivity in serology assays. • Yields of greater than 50 mg/l obtained under optimal conditions. • Magnetic bead purification technology improves throughput of protein production.
Databáze: OpenAIRE